NEW YORK, June 5, 2024 – The Human Immunome Project (HIP) is pleased to announce the appointment of Neema Mgana, PhD to the Board of Directors.
“We are thrilled to have Dr. Mgana join the Human Immunome Project Board and contribute her expertise to our mission,” said Board Chair Jane Metcalfe. “Neema’s multilateral and global programmatic and partnership experience will be a boon to HIP as we continue to build our worldwide, collaborative network to decode and model the immune system.”
Neema has served in the United Nations system in New York, Geneva, and Washington, DC for more than 15 years, focusing on public policy and strategic partnerships for sustainable development and poverty reduction. In these roles she has showcased her deep expertise in developing transformative and multisector partnerships with the private sector, multilateral organizations, civil society, and other development partners. Neema is a serial social entrepreneur and has developed and curated several initiatives and organizations with a focus on health systems and policy, youth empowerment, humanitarian assistance, and poverty reduction. In 2005, she was recognized as one of 1,000 women jointly nominated for the Nobel Peace Prize. She has additionally worked in senior positions with the Firelight Foundation (USA) and the Institute of Finance Management (Tanzania) and has served as a health informatics consultant in Zimbabwe.
“Dr. Mgana is a dynamic strategist committed to global health equity,” said HIP CEO Hans Keirstead, PhD. “I look forward to working together to advance HIP’s mission and ensure that the data and models we produce drive improved health outcomes for all.”
Dr. Mgana received a PhD in International Relations and Diplomacy in Paris, France, a Masters in Global Health from Loma Linda University of Health Science in California, USA, and a Bachelors in Medical Informatics from University of Victoria in British Columbia, Canada.
***
About the Human Immunome Project (HIP)
The Human Immunome Project generates diverse immunological datasets at scale and builds publicly available AI models of the immune system to accelerate medical research and drug discovery, decrease healthcare costs, and improve health worldwide. HIP is a registered nonprofit organization.
Contact
Liza Kane-Hartnett, Liza@ImmunomeProject.org
Responses